Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06132191
Status:
AVAILABLE
Last Update Posted:
2023-11-15
First Post:
2023-11-09
Brief Title:
Expanded Access Use of Cemiplimab in Patients With Solid Tumors
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2023-11-09
First Submit QC Date:
November 9 2023
Study First Post Date:
2023-11-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-09
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL